SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-19-071240
Filing Date
2019-12-10
Accepted
2019-12-10 10:42:49
Documents
1
Period of Report
2019-08-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm1924879d1_3.html 3  
1 OWNERSHIP DOCUMENT tm1924879d1_3.xml 3 3604
  Complete submission text file 0001104659-19-071240.txt   5079
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Issuer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NUVEEN 333 W. WACKER DR. CHICAGO IL 60606
Business Address
Lorenz Kevin (Reporting) CIK: 0001772558 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35366 | Film No.: 191276760